Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study

Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study

Background: Plasma-based biomarkers would be potential biomarkers for early diagnosis of Alzheimer's disease (AD) because they are more available and cost-effective than cerebrospinal fluid (CSF) or neuroimaging. Therefore, we aimed to evaluate whether phosphorylated tau181 (p-tau181) in plasma...

Full description

Bibliographic Details
Main Authors: Yan-Li Wang, Jinglong Chen, Zhong-Li Du, Haoyi Weng, Yuan Zhang, Runzhi Li, Ziyan Jia, Mengfan Sun, Jiwei Jiang, Fang-Ze Wang, Jun Xu, Alzheimer's Disease Neuroimaging Initiative
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Neurology
Subjects:
Alzheimer's disease
plasma p-tau181
cognition
cerebrospinal fluid (CSF)
NeuroImage
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.695696/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.695696/full

Similar Items